Kyowa Hakko Kirin Expands Nespo Use To Predialysis Patients
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin obtained an additional indication for Nespo (darbepoetin alpha) for predialysis in patients with renal anemia to slow progress of renal failure